You have 9 free searches left this month | for more free features.

Condition

Leukemia, Myeloid (1)

Neoplasms (1)

Prostatic Neoplasms (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Celgene (3)

Collaborator

Intervention

cc-90011 (3)

abiraterone (1)

azacitidine (1)

nivolumab (1)

prednisone (1)

venetoclax (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

cc-90011

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Prostatic Tumors Trial in New York (CC-90011, Abiraterone, Prednisone)

Recruiting

Prostatic Neoplasms

CC-90011
+2 more

New York, New York

Memorial Sloan-Kettering Cancer Center

Jul 21, 2022

Leukemia, Myeloid Trial in Worldwide (CC-90011, Venetoclax, Azacitidine)

Completed

Leukemia, Myeloid

CC-90011
+2 more

Duarte, California
+34 more

Apr 26, 2022

Tumors Trial in Worldwide (CC-90011, Nivolumab)

Active, not recruiting

Neoplasms

CC-90011
Nivolumab

Augusta, Georgia
+77 more

Nov 8, 2022